Clincosm LogoSign in Get a demo

Urothelial Carcinoma

Showing 51 - 75 of 239
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Cancer, Urothelial Carcinoma Trial (avelumab (PD-L1 inhibitor immunotherapy) + lurbinectedin)

Not yet recruiting
  • Metastatic Cancer
  • Urothelial Carcinoma
  • avelumab (PD-L1 inhibitor immunotherapy) + lurbinectedin
  • (no location specified)
Dec 19, 2022

Atezolizumab Under Real-World Conditions in Patients Treated in

Recruiting
  • Urothelial Carcinoma
  • +3 more
  • Buenos Aires, Argentina
  • +322 more
Dec 19, 2022

Urothelial Carcinoma Trial in United States (Atezolizumab, Bevacizumab)

Terminated
  • Urothelial Carcinoma
  • Phoenix, Arizona
  • +7 more
Dec 15, 2022

Bladder Cancer, Urothelial Carcinoma, Urothelial Carcinoma Bladder Trial in United States (UGN-102)

Active, not recruiting
  • Bladder Cancer
  • +2 more
  • Homewood, Alabama
  • +4 more
Dec 15, 2022

Bladder Urothelial Carcinoma, Urothelial Carcinoma Trial in Philadelphia (Copper Cu 64 TP3805, Positron Emission Tomography,

Active, not recruiting
  • Bladder Urothelial Carcinoma
  • Urothelial Carcinoma
  • Copper Cu 64 TP3805
  • +2 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Dec 13, 2022

Urothelial Carcinoma Trial in China (Tislelizumab, Placebo, Cisplatin)

Recruiting
  • Urothelial Carcinoma
  • Hefei, Anhui, China
  • +40 more
Dec 14, 2022

Bladder Cancer, Urothelial Carcinoma, Hematuria Trial (Urinalysis)

Not yet recruiting
  • Bladder Cancer
  • +3 more
  • Urinalysis
  • (no location specified)
Dec 1, 2022

Efficacy and Utility of Cxbladder Tests in Hematuria Patients

Recruiting
  • Hematuria
  • Urothelial Carcinoma
  • Cxbladder
  • San Diego, California
  • +6 more
Dec 8, 2022

Non Small Cell Lung Cancer, Cutaneous Melanoma, Head and Neck Squamous Cell Carcinoma Trial in United States (RTX-224)

Terminated
  • Non Small Cell Lung Cancer
  • +4 more
  • Scottsdale, Arizona
  • +4 more
Dec 7, 2022

Renal Cell Carcinoma (RCC), Urothelial Carcinoma, Primary Peritoneal Cancer Trial in Canada, United States (DSP-7888 Dosing

Completed
  • Renal Cell Carcinoma (RCC)
  • +5 more
  • DSP-7888 Dosing Emulsion
  • +2 more
  • Tucson, Arizona
  • +18 more
Dec 6, 2022

Patients With Advanced Urothelial Carcinoma

Active, not recruiting
  • Urothelial Carcinoma
    • Los Angeles, California
    • +40 more
    Dec 7, 2022

    Urothelial Carcinoma Trial in France, Italy, United States (retifanlimab, epacadostat, INCAGN02385)

    Recruiting
    • Urothelial Carcinoma
    • Iowa City, Iowa
    • +11 more
    Dec 1, 2022

    Advanced Solid Tumor, MSI-H/dMMR Tumors, Cutaneous Squamous Cell Carcinoma Trial in Worldwide (INCB099280)

    Recruiting
    • Advanced Solid Tumor
    • +11 more
    • Boston, Massachusetts
    • +30 more
    Dec 1, 2022

    Advanced or Metastatic Solid Tumors, Lung Cancer, Breast Cancer Trial in United States (NC318)

    Active, not recruiting
    • Advanced or Metastatic Solid Tumors
    • +8 more
    • Los Angeles, California
    • +5 more
    Nov 29, 2022

    Kidney Cancer, Renal Cell Carcinoma, Clear Cell Carcinoma Trial in Dallas (13C-Glucose, 13C-Acetate, 13C-Lactate)

    Recruiting
    • Kidney Cancer
    • +11 more
    • 13C-Glucose
    • +4 more
    • Dallas, Texas
      University of Texas Southwestern Medical Center
    Dec 1, 2022

    Melanoma, Breast Carcinoma, Hepatocellular Carcinoma Trial in United States (XmAb20717)

    Completed
    • Melanoma
    • +27 more
    • XmAb20717
    • Los Angeles, California
    • +16 more
    Nov 29, 2022

    Muscle Invasive Bladder Cancer, Urothelial Carcinoma Trial in Tianjin (Tislelizumab, Nab paclitaxel)

    Active, not recruiting
    • Muscle Invasive Bladder Cancer
    • Urothelial Carcinoma
    • Tianjin, Tianjin, China
      Tianjin Medical University Second Hospital
    Nov 23, 2022

    Urothelial Carcinoma, Metastatic Cancer Trial in Houston (Pemetrexed, Zimberelimab, Etrumadenant)

    Not yet recruiting
    • Urothelial Carcinoma
    • Metastatic Cancer
    • Houston, Texas
      MD Anderson Cancer Center
    Nov 28, 2022

    Bladder Cancer, Metastatic Bladder Cancer, Urothelial Carcinoma Trial in United States (Atezolizumab, Gemcitabine, Cisplatin)

    Active, not recruiting
    • Bladder Cancer
    • +2 more
    • Hartford, Connecticut
    • +10 more
    Nov 23, 2022

    Stage IV Bladder Urothelial Carcinoma, Prostate Cancer, Urothelial Carcinoma Trial in United States (procedure, other,

    Recruiting
    • Stage IV Bladder Urothelial Carcinoma
    • +2 more
    • Computed Tomography
    • +4 more
    • Duarte, California
    • +8 more
    Nov 19, 2022

    Bladder Carcinoma, Bladder Urothelial Carcinoma, Muscle Invasive Bladder Carcinoma Trial in Toronto (biological, procedure,

    Recruiting
    • Bladder Carcinoma
    • +7 more
    • Atezolizumab
    • +5 more
    • Toronto, Ontario, Canada
      University Health Network Princess Margaret Cancer Center LAO
    Nov 8, 2022

    Hepatocellular Carcinoma, Metastatic Castration Resistant Prostate Cancer, Renal Cell Carcinoma Trial in United States (Part 1

    Active, not recruiting
    • Hepatocellular Carcinoma
    • +11 more
    • Part 1 TPST-1120
    • +3 more
    • San Francisco, California
    • +10 more
    Nov 1, 2022

    Urothelial Carcinoma Trial (Avelumab)

    Not yet recruiting
    • Urothelial Carcinoma
    • (no location specified)
    Oct 26, 2022

    Bladder Cancer, Urothelial Carcinoma Trial in Denmark (Electronic patient-reported outcomes)

    Completed
    • Bladder Cancer
    • Urothelial Carcinoma
    • Electronic patient-reported outcomes
    • Aalborg, Denmark
    • +3 more
    Oct 24, 2022

    Urothelial Carcinoma Trial in Iowa City (Avelumab, Docetaxel)

    Active, not recruiting
    • Urothelial Carcinoma
    • Iowa City, Iowa
      University of Iowa Hospitals and Clinics
    Oct 18, 2022